GlassScriptPhysician profile
Abdrhaman Hamo
NPI 1295949907
$10,990.25
in general payments reported to CMS, 2019-2025
37 companies · $1,130 in 2025
The $1,130 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,338 · 2020: $1,218 · 2021: $1,910 · 2022: $1,992 · 2023: $1,796 · 2024: $1,606 · 2025: $1,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,532.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,343.75 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Novartis Pharmaceuticals Corporation | $1,248.79 | 2019-2024 | |
| Shockwave Medical, INC | $1,085.34 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Boston Scientific Corporation | $1,063.92 | 2019-2025 | Avvigo Guidance System, Comet, General - Balloon Catheters |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $974.06 | 2019-2025 | Lifevest |
| Abbott Laboratories | $717.55 | 2020-2025 | Aveir, Jot Dx, Gallant |
| Kestra Medical Technology Services, INC. | $599.24 | 2022-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $490.90 | 2019-2024 | Camzyos |
| Abiomed | $421.21 | 2020-2025 | Impella |
| Medtronic, INC. | $418.02 | 2021-2024 | Onyx Frontier |
| Janssen Pharmaceuticals, INC | $409.51 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $313.22 | 2019-2020 | |
| Cardiovascular Systems INC. | $228.04 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.96 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $167.37 | 2021-2025 | Verquvo |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $150.74 | 2020-2025 | Repatha |
| Terumo Medical Corporation | $118.17 | 2019-2020 | |
| Osprey Medical INC | $112.63 | 2020-2021 | |
| Philips North America LLC | $110.79 | 2019-2024 | (5044) Mcot, (Bq9) Coronary Ivus |
| Pfizer INC. | $108.88 | 2019-2024 | |
| Amarin Pharma, INC. | $108.76 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $105.57 | 2023-2024 | Inpefa |
| Penumbra, INC. | $81.58 | 2023-2025 | Indigo System, Penumbra System |
| Cvrx, INC. | $71.45 | 2024 | Barostim Neo System |
| Novo Nordisk INC | $62.36 | 2024 | Ozempic, Wegovy |
| Esperion Therapeutics, INC. | $57.06 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $47.21 | 2021-2022 | |
| Vital Connect, INC | $29.14 | 2022 | |
| Daiichi Sankyo INC. | $20.01 | 2023 | Injectafer |
| Teleflex LLC | $19.39 | 2025 | Orsiro Mission |
| Bayer Healthcare Pharmaceuticals INC. | $18.51 | 2025 | |
| Bard Peripheral Vascular, INC. | $17.74 | 2020 | |
| Opsens INC. | $15.77 | 2020 | |
| Vifor Pharma, INC. | $14.58 | 2021 | |
| Bardy Diagnostics, INC. | $13.56 | 2022 | |
| Akcea Therapeutics, INC. | $13.39 | 2019 | |
| Verge Medical, INC. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdrhaman Hamo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.